Outcomes of first-line FOLFIRINOX (FFX) versus gemcitabine and nab-paclitaxel (GN) in patients with advanced pancreatic cancer: Multi-Institutional Canadian sites experienceNeha Papneja, Petr Kavan, Abhishek Papneja et al.|Annals of Oncology|2019Cited by 1
280P Outcomes of women with early-stage triple-negative breast cancer (TNBC) in connection with age and other socio-demographic factors: A population based cohort studyShahid Ahmed, Philip Wright, Osama Ahmed et al.|ESMO Open|2024Cited by 0